Keyphrases
African American
100%
Fixed-dose Combination
100%
Elderly Patients
100%
Heart Failure Trials
100%
Hydralazine
100%
Isosorbide Dinitrate
100%
Improved Outcomes
50%
Age Groups
50%
Event-free Survival
50%
Hazard Ratio
50%
Neurohormonal
50%
Heart Failure Patients
25%
Acute Decompensated Heart Failure
25%
Ischemic Heart Failure
25%
Heart Failure Hospitalization
25%
Quality of Life Improvement
25%
Quality of Life Assessment
25%
B-type Natriuretic Peptide
25%
Treatment Effect
25%
Mortality Risk
25%
Hypertensive
25%
Cox Proportional Hazards Model
25%
Directional Effects
25%
Baseline Characteristics
25%
Kaplan-Meier Curve
25%
Survival Benefit
25%
Creatinine Level
25%
Kaplan-Meier Method
25%
Time-to-event
25%
Heart Failure Events
25%
Nursing and Health Professions
Elderly Patient
100%
Congestive Heart Failure
100%
Isosorbide Dinitrate/Hydralazine
100%
Hazard Ratio
28%
Kaplan Meier Method
28%
Event Free Survival
28%
Quality of Life
14%
Proportional Hazards Model
14%
Creatinine
14%
Heart Muscle Ischemia
14%
Brain Natriuretic Peptide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hydralazine
100%
Congestive Heart Failure
100%
Isosorbide Dinitrate
100%
Event Free Survival
28%
Heart Muscle Ischemia
14%
Creatinine
14%
Brain Natriuretic Peptide
14%